August 15, 2012 — Mission Search Corp., a Tampa, Fla.-based healthcare search and staffing organization, announced it has joined with Sensus Healthcare to provide commissioning services to Sensus’ clientele.

Sensus Healthcare is taking new aim by focusing on the design, manufacture and marketing of products and services that incorporate proprietary mobile X-ray technology for cost-effective, noninvasive treatment of non-melanoma skin cancers. The company’s SRT-100 meets the safety requirements set by the U.S. Food and Drug Administration (FDA), UL and ISO/CE mark certification.

Based in Boca Raton, Fla., Sensus Healthcare employs best-practice standard operational procedures to ensure quality control, high-grade customer support, optimized success in field operations and product reliability.

“We are pleased to partner with Sensus Healthcare to provide medical physics commissioning services for their superficial radiation therapy (SRT) systems and ultimately assisting Sensus as it brings non-melanoma skin cancer treatment to more patients in more settings,” said John Astrab, president and CEO of Mission Search Corp.

Added Joe Sardano, president and CEO of Sensus Healthcare: “We are excited to be partnering with the Mission Search team. We both share the same values when it comes to customer service and satisfaction. We are very much looking forward to growing our business with another great partner as the need for SRT continues to evolve.”

For more information: www.sensushealthcare.com, www.missionsearch.com


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now